|
1
|
Witz IP: The tumor microenvironment: the
making of a paradigm. Cancer Microenviron. 2(Suppl 1): 9–17. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mueller MM and Fusenig NE: Friends or foes
- bipolar effects of the tumor stroma in cancer. Nat Rev Cancer.
4:839–849. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barsky SH, Green WR, Grotendorst GR and
Liotta LA: Desmoplastic breast carcinoma as a source of human
myofibroblasts. Am J Pathol. 115:329–333. 1984.PubMed/NCBI
|
|
4
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar
|
|
5
|
Zou WP: Immunosuppressive networks in the
tumor environment and their therapeutic relevance. Nat Rev Cancer.
5:263–274. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bergmann C, Strauss L, Zeidler R, Lang S
and Whiteside TL: Expansion and characteristics of human T
regulatory type 1 cells in co-cultures simulating tumor
microenvironment. Cancer Immunol Immunother. 56:1429–1442. 2007.
View Article : Google Scholar
|
|
7
|
Zou WP, Machelon V, Coulomb-L’Hermin A, et
al: Stromal-derived factor-1 in human tumors recruits and alters
the function of plasmacytoid precursor dendritic cells. Nat Med.
7:1339–1346. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iwamoto M, Shinohara H, Miyamoto A, et al:
Prognostic value of tumor-infiltrating dendritic cells expressing
CD83 in human breast carcinomas. Int J Cancer. 104:92–97. 2003.
View Article : Google Scholar
|
|
9
|
Gao F, Hui X, He X, Wan D and Gu J:
Dysfunction of murine dendritic cells induced by incubation with
tumor cells. Cell Mol Immunol. 5:133–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan XL, Chen L, Zhang TT, et al: Gastric
cancer cells induce human CD4+Foxp3+
regulatory T cells through the production of TGF-β1. World J
Gastroenterol. 17:2019–2027. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sempere LF, Gunn JR and Korc M: A novel
3-dimensional culture system uncovers growth stimulatory actions by
TGFβ in pancreatic cancer cells. Cancer Biol Ther. 12:198–207.
2011.PubMed/NCBI
|
|
12
|
Yi T, Li X, Yao S, et al: Host APCs
augment in vivo expansion of donor natural regulatory T cells via
B7H1/B7.1 in allogeneic recipients. J Immunol. 186:2739–2749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou X, Zhou Y, Ding Q, et al: High level
expression of B7H1 molecules by keratinocytes suppresses xeno- and
allo-reactions by inducing type I regulatory T cells. Transpl
Immunol. 21:192–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hori J, Taniguchi H, Wang M, Oshima M and
Azuma M: GITR ligand-mediated local expansion of regulatory T cells
and immune privilege of corneal allografts. Invest Ophthalmol Vis
Sci. 51:6556–6565. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim JI, Sonawane SB, Lee MK, et al:
Blockade of GITR-GITRL interaction maintains Treg function to
prolong allograft survival. Eur J Immunol. 40:1369–1374. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Häkkinen L, Koivisto L and Larjava H: An
improved method for culture of epidermal keratinocytes from newborn
mouse skin. Methods Cell Sci. 23:189–196. 2011.PubMed/NCBI
|
|
17
|
Gao FG, Li HT, Li ZJ and Gu JR: Nicotine
stimulated dendritic cells could achieve anti-tumor effects in
mouse lung and liver cancer. J Clin Immunol. 31:80–88. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang MH, Tang H, Guo ZH, et al: Splenic
stroma drives mature dendritic cells to differentiate into
regulatory dendritic cells. Nat Immunol. 5:1124–1133. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ruan Q, Kameswaran V, Tone Y, et al:
Development of Foxp3(+) regulatory T cells is driven by the c-Rel
enhanceosome. Immunity. 31:932–940. 2009.
|
|
20
|
Massague J: TGF-beta and cancer. Cell.
134:215–230. 2008. View Article : Google Scholar
|
|
21
|
Alshaker HA and Matalka KZ: IFN-γ, IL-17
and TGF-β involvement in shaping the tumor microenvironment: the
significance of modulating such cytokines in treating malignant
solid tumors. Cancer Cell Int. 11:332011.
|
|
22
|
Yang L, Pang Y and Moses HL: TGF-β and
immune cells: an important regulatory axis in the tumor
microenvironment and progression. Trends Immunol. 31:220–227.
2010.
|
|
23
|
Siegel PM and Massague J: Cytostatic and
apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev
Cancer. 3:807–821. 2003.
|
|
24
|
Orsini E, Guarini A, Chiaretti S, Mauro FR
and Foa R: The circulating dendritic cell compartment in patients
with chronic lymphocytic leukemia is severely defective and unable
to stimulate an effective T-cell response. Cancer Res.
63:4497–4506. 2003.
|
|
25
|
Sharma S, Stolina M, Yang SC, et al: Tumor
cyclooxygenase 2-dependent suppression of dendritic cell function.
Clin Cancer Res. 9:961–968. 2003.PubMed/NCBI
|
|
26
|
Yang AS and Lattime EC: Tumor-induced
interleukin 10 suppresses the ability of splenic dendritic cell to
stimulate CD4 and CD8 T-cell responses. Cancer Res. 63:2150–2157.
2003.PubMed/NCBI
|
|
27
|
Nam JS, Terabe M, Kang MJ, et al:
Transforming growth factor beta subverts the immune system into
directly promoting tumor growth through interleukin-17. Cancer Res.
68:3915–3923. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gorska AE, Jensen RA, Shyr Y, Aakre ME,
Bhowmick NA and Moses HL: Transgenic mice expressing a
dominant-negative mutant type II transforming growth factor beta
receptor exhibit impaired mammary development and enhanced mammary
tumor formation. Am J Pathol. 163:1539–1549. 2003. View Article : Google Scholar
|
|
29
|
Scholzen A, Mittag D, Rogerson SJ, Cooke
BM and Plebanski M: Plasmodium falciparum-mediated induction of
human CD25hiFoxp3hi CD4 T cells is
independent of direct TCR stimulation and requires IL-2, IL-10 and
TGFβ. PLoS Pathog. 5:e10005432009.PubMed/NCBI
|
|
30
|
Bettelli E, Carrier Y, Gao W, et al:
Reciprocal developmental pathways for the generation of pathogenic
effector TH17 and regulatory T cells. Nature. 441:235–238. 2006.
View Article : Google Scholar
|
|
31
|
Kretschmer K, Apostolou I, Hawiger D,
Khazaie K, Nussenzweig MC and von Boehmer H: Inducing and expanding
regulatory T cell populations by foreign antigen. Nat Immunol.
6:1219–1227. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lafaille C, Kutchukhidze MA, Shen N, Ding
S, Yee YH and Lafaille JJ: Adaptive Foxp3+ regulatory T
cell-dependent and -independent control of allergic inflammation.
Immunity. 29:114–126. 2008.
|
|
33
|
Yamazaki S, Iyoda T, Tarbell K, Olson K,
Velinzon K, Inaba K and Steinman RM: Direct expansion of functional
CD25+ CD4+ regulatory T cells by
antigen-processing dendritic cells. J Exp Med. 198:235–247.
2003.PubMed/NCBI
|
|
34
|
Benson MJ, Pino-Lagos K, Rosemblatt M and
Noelle RJ: All-trans retinoic acid mediates enhanced T reg cell
growth, differentiation, and gut homing in the face of high levels
of co-stimulation. J Exp Med. 204:1765–1774. 2007. View Article : Google Scholar : PubMed/NCBI
|
